UBS Reiterates Buy Rating on Edwards Lifesciences (EW)

October 8, 2026 9:34 AM EDT Send to a Friend
UBS analyst Patrick Wood reiterated a Buy rating and $110.00 price target on Edwards Lifesciences (NYSE: EW).The analyst commented, "Predicting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login